About
505(b)(2) drugs
Areas of Focus
Categories
NJ, NY, PA
Team (1)
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
627
By Phase
PHASE2: 2PHASE3: 1
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05348200Lead Sponsor
Safety and Efficacy of CITI-002 in Adult Patients With Moderate Grade Hemorrhoids
PHASE2Completed
304 participants
Started: Apr 22, 2022 · Completed: May 17, 2023
NCT02689856Lead Sponsor
Safety and Efficacy of Hydrocortisone and Lidocaine Treatment of Grade I and II Hemorrhoids
PHASE2Completed
211 participants
Started: May 31, 2015 · Completed: Oct 31, 2015
NCT01871727Collaborator
A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma
PHASE3Completed
112 participants
Started: May 30, 2013 · Completed: Dec 14, 2021
Locations (1)
Headquarters
Cranford, NJ, United States
Map
Loading map...